Noah Berkowitz
Chief Executive Officer, Synvista Therapeutics, Inc.
Companies
- Arvinas (United States)Chief Medical Officer Mar 21, 2024 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Arvinas (United States) ARVN191,395 shares2$1.4M at $7.18May 11, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- May 11, 2026Sold 11,108 shares at $9.94 of Arvinas (United States)2
- Mar 18, 2026Sold 6,435 shares at $11.10 of Arvinas (United States)3
- Feb 26, 2026Granted 45,000 shares of Arvinas (United States)4
- Feb 13, 2026Sold 5,685 shares at $11.89 of Arvinas (United States)5
- May 9, 2025Granted 59,600 shares of Arvinas (United States)6
- Mar 18, 2025Sold 8,658 shares at $8.59 of Arvinas (United States)7
- Feb 13, 2025Granted 55,229 shares of Arvinas (United States)8
- Mar 18, 2024Granted 63,452 shares of Arvinas (United States)9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 19, 2026
- 4SEC EDGARForm 4 filed Mar 2, 2026
- 5SEC EDGARForm 4 filed Feb 18, 2026
- 6SEC EDGARForm 4 filed May 13, 2025
- 7SEC EDGARForm 4 filed Mar 19, 2025
- 8SEC EDGARForm 4 filed Feb 18, 2025
- 9SEC EDGARForm 4 filed Mar 21, 2024